Search

Your search keyword '"Hua, Fang"' showing total 2,452 results

Search Constraints

Start Over You searched for: Author "Hua, Fang" Remove constraint Author: "Hua, Fang" Database OpenAIRE Remove constraint Database: OpenAIRE
2,452 results on '"Hua, Fang"'

Search Results

5. All-Optical Reconfigurable Excitonic Charge States in Monolayer MoS2

8. Impact of aging on the sources, volatility, and viscosity of organic aerosols in Chinese outflows

13. p53/p21 Inhibits Osteoarthritis Progression by Regulating Chondrocyte Pyroptosis

16. Bending and punching characteristics of aluminum sheets using the quasi-continuum method

18. Triazole resistance in Aspergillus fumigatus exposed to new chiral fungicide mefentrifluconazole

19. MCAD activation by empagliflozin promotes fatty acid oxidation and reduces lipid deposition in NASH

20. 3D nanoprinting of semiconductor quantum dots by photoexcitation-induced chemical bonding

23. Accessibility of Urban Nonprofit Public Nursery Services Based on Big Data

24. A Multilevel Biosensor-Based Epidemic Simulation Model for COVID-19

25. Uptake, Accumulation, and translocation of azoxystrobin by Vegetable plants in soils: influence of soil characteristics and plant species

28. Feature Extraction Method Based on Filter Banks and Riemannian Tangent Space in Motor-Imagery BCI

30. Effectiveness of early glucocorticoids in myasthenia gravis: A retrospective cohort study

31. Disentangling Dual Emission Dynamics in Lead Bromide Perovskite

33. Supplementary Table S2 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

35. Data from Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

36. Supplementary Data from Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

37. Supplementary Figure S1 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

38. Supplementary Figure S2 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

39. Supplementary Table S3 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

40. Fig S2 from Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

41. Fig S1 from Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

42. Supplementary Table S1 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

43. Data from Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma

44. Supplementary Figure S3 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

45. Lipidome remodeling activities of DPA-EA in palmitic acid-stimulated HepG2 cells and the in vivo anti-obesity effect of the DPA-EA and DHA-EA mixture prepared from algae oil

47. A review of harmonization methods for studying dietary patterns

Catalog

Books, media, physical & digital resources